You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Haploidentical hematopoietic stem cell transplantation

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Haploidentical Hematopoietic Stem Cell Transplantation Trial in Seoul (ATG-LDPTCy)

Recruiting
  • Haploidentical Hematopoietic Stem Cell Transplantation
  • Seoul, Korea, Republic of
    Samsung Medical Center
Sep 11, 2023

Hematopoietic Organs; Disorder Trial in Hong Kong (CD62L depleted donor lymphocyte infusion)

Recruiting
  • Hematopoietic Organs; Disorder
  • CD62L depleted donor lymphocyte infusion
  • Hong Kong, Hong Kong
    Hong Kong Children's Hospital
Sep 6, 2023

Hematopoietic Organs; Disorder Trial in Hong Kong (Total lymphoid irradiation)

Recruiting
  • Hematopoietic Organs; Disorder
  • Total lymphoid irradiation
  • Hong Kong, Hong Kong
    Hong Kong Children's Hospital
Oct 4, 2023

Blood Virome After Haploidentical Hematopoietic Stem Cell

Recruiting
  • Haploidentical Hematopoietic Stem Cell Transplantation
    • Geneva, Switzerland
      Geneva University Hospitals
    Nov 21, 2022

    Acute Lymphoblastic Leukemia Trial in Hangzhou (Blinatumomab)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Nov 5, 2023

    Hematopoietic Stem Cell Transplantation, Acute Leukemia Trial in Suzhou (Individual ATG, ATG)

    Recruiting
    • Hematopoietic Stem Cell Transplantation
    • Acute Leukemia
    • Individual ATG
    • ATG
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Dec 12, 2022

    Acute Leukemia Trial in Tianjin (Combined haploidentical and umbilical cord blood allogeneic stem cell transplantation,

    Recruiting
    • Acute Leukemia
    • Combined haploidentical and umbilical cord blood allogeneic stem cell transplantation
    • haploidentical hematopoietic stem cell transplantation
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital, Chinese Acade
    Aug 9, 2022

    The Optimization of Haploidentical Hematopoietic Stem Cell

    Not yet recruiting
    • Hematological Malignancy
    • ATG
    • Post-transplantation cyclophosphamide
    • Beijing, Beijing, China
      People's Hospital of Peking University
    Nov 28, 2022

    Pediatric Hematologic Malignancies Trial in Saint Louis (Ex Vivo T-cell receptor alpha-beta and CD19+ Depletion using CliniMACs

    Not yet recruiting
    • Pediatric Hematologic Malignancies
    • Ex Vivo T-cell receptor alpha-beta and CD19+ Depletion using CliniMACs Plus
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jul 20, 2022

    Haploidentical Hematopoietic Stem Cell Transplantation Trial in Beijing (Individual Antithymocyte globulin, Antithymocyte

    Recruiting
    • Haploidentical Hematopoietic Stem Cell Transplantation
    • Individual Antithymocyte globulin
    • Antithymocyte globulin
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Jan 15, 2022

    Haploidentical Hematopoietic Stem Cell Transplantation Trial in Beijing (Antithymocyte Globulin)

    Recruiting
    • Haploidentical Hematopoietic Stem Cell Transplantation
    • Antithymocyte Globulin
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Dec 12, 2021

    The Incidence of Peripheral Blood CMV Activation and Confirmed Clinically Significant CMV Infection Within 24 Weeks After

    Not yet recruiting
    • The Incidence of Peripheral Blood CMV Activation and Confirmed Clinically Significant CMV Infection Within 24 Weeks After Transplantation
    • (no location specified)
    Jun 13, 2023

    Sickle Cell Disease Trial in Chicago (aß+ T-cell depletion with Miltenyi CliniMACS system)

    Recruiting
    • Sickle Cell Disease
    • αβ+ T-cell depletion with Miltenyi CliniMACS system
    • Chicago, Illinois
      The University of Chicago
    May 13, 2022

    To Evaluate the Efficacy and Safety of Secondary Prophylaxis of CMV Reactivation Trial (Letermovir for secondary prophylaxis)

    Not yet recruiting
    • To Evaluate the Efficacy and Safety of Secondary Prophylaxis of CMV Reactivation
    • Letermovir for secondary prophylaxis
    • (no location specified)
    Jun 13, 2023

    Haplo-identical Transplantation, Transplantation Trial in Paris (Evaluate the evolution of the psychic state of the donors

    Not yet recruiting
    • Haplo-identical Transplantation
    • Transplantation
    • Evaluate the evolution of the psychic state of the donors (ascendants and descendants), by means of questionnaires, within the framework of haplo-identical allograft.
    • Paris, France
      Service D'hématologie Clinique et thérapie cellulaire - Hôpital
    Oct 17, 2023

    Hematological Malignancy Trial (Thymoglobulin Injectable Product)

    Not yet recruiting
    • Hematological Malignancy
    • Thymoglobulin Injectable Product
    • (no location specified)
    Sep 27, 2023

    Graft Vs Host Disease Trial in New York (Cyclophosphamide, Abatacept, Tacrolimus)

    Recruiting
    • Graft Vs Host Disease
    • New York, New York
      NYU Langone Health
    Nov 10, 2022

    Graft-versus-host Disease Trial in New York (Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention)

    Active, not recruiting
    • Graft-versus-host Disease
    • Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention
    • New York, New York
      NYU Langone Health
    Aug 5, 2022

    Sickle Cell-thalassemia Disease, Thalassemia Trial in Washington (peripheral blood stem cell graft that are CD34+ selected)

    Active, not recruiting
    • Sickle Cell-thalassemia Disease
    • Thalassemia
    • peripheral blood stem cell graft that are CD34+ selected
    • Washington, District of Columbia
      Childrens National Medical Center
    Jul 15, 2021

    Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (haploidentical stem cell transplant,

    Recruiting
    • Sickle Cell Disease
    • haploidentical stem cell transplant
    • +5 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 18, 2022

    Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Westwood (EAGD T-cell infusion (Phase

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • EAGD T-cell infusion (Phase I)
    • EAGD T-cell infusion (Expansion)
    • Westwood, Kansas
      University of Kansas Cancer Center
    Mar 15, 2022

    Recurrent Severe Aplastic Anemia, Refractory Severe Aplastic Anemia Trial in Duarte (biological, procedure, drug, other)

    Not yet recruiting
    • Recurrent Severe Aplastic Anemia
    • Refractory Severe Aplastic Anemia
    • Anti-Thymocyte Globulin
    • +7 more
    • Duarte, California
      City of Hope Medical Center
    Feb 23, 2023

    Hematologic Malignancy Trial in Tuebingen,, Tuebingen (CD45RA depleted donor lymphocyte infusion (DLI))

    Recruiting
    • Hematologic Malignancy
    • CD45RA depleted donor lymphocyte infusion (DLI)
    • Tuebingen,, Germany
    • +1 more
    Jul 13, 2023

    Sickle Cell Disease Trial in Duarte (Hematopoietic stem cell transplantation)

    Recruiting
    • Sickle Cell Disease
    • Hematopoietic stem cell transplantation
    • Duarte, California
      City of Hope Medical Center
    Jun 14, 2022

    Relapsed Pediatric ALL, Acute GVHD (Gvhd) Grade IV (Diagnosis), Relapsed Pediatric AML Trial (In Vitro T cells depletion using

    Recruiting
    • Relapsed Pediatric ALL
    • +2 more
    • In Vitro T cells depletion using CliniMCAS system
    • Shanghai, China
      Shanghai Children's Medical Center
    Sep 28, 2022